Prudential Financial’s aTyr Pharma ATYR Stock Holding History

Prudential Financial’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,660	Closed	-$11.4K	–	2606
2026 Q1	$11.4K	Buy	+14,660	New	+$12.4K	﹤0.01%	2393
2025 Q4	–	Sell	-10,890	Closed	-$7.84K	–	2473
2025 Q3	$7.84K	Sell	10,890 -1,500	-12%	-$6.8K	﹤0.01%	2411
2025 Q2	$62.8K	Buy	+12,390	New	+$48.7K	﹤0.01%	2324
2024 Q2	–	Sell	-16,000	Closed	-$31.2K	–	2806
2024 Q1	$31.2K	Buy	16,000 +800	+5%	+$1.4K	﹤0.01%	2629
2023 Q4	$21.4K	Buy	+15,200	New	+$19.5K	﹤0.01%	2613

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prudential Financial's ATYR Position: Q2 2026 in Review

Prudential Financial sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 14,660 shares — an estimated $11.4K sold.

Prudential Financial first reported a position in ATYR in Q4 2023 and held it in 5 quarters. The position peaked at $62.8K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Prudential Financial reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
Prudential Financial sold 14,660 aTyr Pharma shares in Q2 2026, an estimated $11.4K.
Prudential Financial first reported a position in aTyr Pharma in Q4 2023 and held it in 5 quarters.
Prudential Financial's aTyr Pharma position peaked at $62.8K in Q2 2025.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.